Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.
2.

Viral envelope protein glycosylation is a molecular determinant of the neuroinvasiveness of the New York strain of West Nile virus.

Shirato K, Miyoshi H, Goto A, Ako Y, Ueki T, Kariwa H, Takashima I.

J Gen Virol. 2004 Dec;85(Pt 12):3637-45.

PMID:
15557236
3.

Glycosylation of the West Nile Virus envelope protein increases in vivo and in vitro viral multiplication in birds.

Murata R, Eshita Y, Maeda A, Maeda J, Akita S, Tanaka T, Yoshii K, Kariwa H, Umemura T, Takashima I.

Am J Trop Med Hyg. 2010 Apr;82(4):696-704. doi: 10.4269/ajtmh.2010.09-0262.

4.

West Nile 25A virus infection of B-cell-deficient ((micro)MT) mice: characterization of neuroinvasiveness and pseudoreversion of the viral envelope protein.

Chambers TJ, Droll DA, Walton AH, Schwartz J, Wold WS, Nickells J.

J Gen Virol. 2008 Mar;89(Pt 3):627-35. doi: 10.1099/vir.0.83297-0.

PMID:
18272752
5.

DC-SIGN enhances infection of cells with glycosylated West Nile virus in vitro and virus replication in human dendritic cells induces production of IFN-alpha and TNF-alpha.

Martina BE, Koraka P, van den Doel P, Rimmelzwaan GF, Haagmans BL, Osterhaus AD.

Virus Res. 2008 Jul;135(1):64-71. doi: 10.1016/j.virusres.2008.02.008. Epub 2008 Apr 10.

PMID:
18405996
7.

A glycosylated peptide in the West Nile virus envelope protein is immunogenic during equine infection.

Hobson-Peters J, Toye P, Sánchez MD, Bossart KN, Wang LF, Clark DC, Cheah WY, Hall RA.

J Gen Virol. 2008 Dec;89(Pt 12):3063-72. doi: 10.1099/vir.0.2008/003731-0.

PMID:
19008394
8.

Tumor necrosis factor alpha protects against lethal West Nile virus infection by promoting trafficking of mononuclear leukocytes into the central nervous system.

Shrestha B, Zhang B, Purtha WE, Klein RS, Diamond MS.

J Virol. 2008 Sep;82(18):8956-64. doi: 10.1128/JVI.01118-08. Epub 2008 Jul 16.

9.

West Nile virus envelope protein: role in diagnosis and immunity.

Wang T, Anderson JF, Magnarelli LA, Bushmich S, Wong S, Koski RA, Fikrig E.

Ann N Y Acad Sci. 2001 Dec;951:325-7.

PMID:
11797789
10.

Different chemokine expression in lethal and non-lethal murine West Nile virus infection.

Shirato K, Kimura T, Mizutani T, Kariwa H, Takashima I.

J Med Virol. 2004 Nov;74(3):507-13.

PMID:
15368509
11.

Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and -independent mechanisms.

Daffis S, Samuel MA, Keller BC, Gale M Jr, Diamond MS.

PLoS Pathog. 2007 Jul 27;3(7):e106.

12.

Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection.

Daffis S, Samuel MA, Suthar MS, Keller BC, Gale M Jr, Diamond MS.

J Virol. 2008 Sep;82(17):8465-75. doi: 10.1128/JVI.00918-08. Epub 2008 Jun 18.

13.

A recombinant envelope protein vaccine against West Nile virus.

Ledizet M, Kar K, Foellmer HG, Wang T, Bushmich SL, Anderson JF, Fikrig E, Koski RA.

Vaccine. 2005 Jun 10;23(30):3915-24. Epub 2005 Apr 6.

PMID:
15917113
14.

Cytokine and nitric oxide production by mouse macrophages infected with Brazilian flaviviruses.

Barros VE, Ferreira BR, Livonesi M, Figueiredo LT.

Rev Inst Med Trop Sao Paulo. 2009 May-Jun;51(3):141-7.

15.

Neutralization escape variant of West Nile virus associated with altered peripheral pathogenicity and differential cytokine profile.

Sapkal GN, Harini S, Ayachit VM, Fulmali PV, Mahamuni SA, Bondre VP, Gore MM.

Virus Res. 2011 Jun;158(1-2):130-9. doi: 10.1016/j.virusres.2011.03.023. Epub 2011 Apr 4.

PMID:
21470570
16.

Up-regulation of IL-6 and TNF-alpha induced by SARS-coronavirus spike protein in murine macrophages via NF-kappaB pathway.

Wang W, Ye L, Ye L, Li B, Gao B, Zeng Y, Kong L, Fang X, Zheng H, Wu Z, She Y.

Virus Res. 2007 Sep;128(1-2):1-8. Epub 2007 May 25.

PMID:
17532082
18.

Attenuated West Nile viruses bearing 3'SL and envelope gene substitution mutations.

Yu L, Robert Putnak J, Pletnev AG, Markoff L.

Vaccine. 2008 Nov 5;26(47):5981-8. doi: 10.1016/j.vaccine.2008.08.064. Epub 2008 Sep 19.

PMID:
18805457
19.

Increased pathogenicity of West Nile virus (WNV) by glycosylation of envelope protein and seroprevalence of WNV in wild birds in Far Eastern Russia.

Kariwa H, Murata R, Totani M, Yoshii K, Takashima I.

Int J Environ Res Public Health. 2013 Dec 12;10(12):7144-64. doi: 10.3390/ijerph10127144. Review.

20.

Supplemental Content

Support Center